NCT00943358View on ClinicalTrials.gov

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Influenza

Interventions

BIOLOGICAL

MF59 H1N1 vaccine

3.75-7.5ug dose

BIOLOGICAL

Plain H1N1 vaccine

7.5-15ug

Trial Locations (1)

LE1 5WW

University Hospitals Leicester, Leicester

Sponsors

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Public Health England

OTHER_GOV

collaborator

Novartis Vaccines

INDUSTRY

lead

University Hospitals, Leicester

OTHER